MSC-Exosome Therapy for Frontotemporal Dementia | MicrobiomeTrials← Back to trialsNCT07638813
MSC-Exosome Therapy for Frontotemporal Dementia
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-10-31
Enrollment target: 33 participants Other microbiome trials you might be interested in
Alzheimer DiseaseDementiaPrimary Progressive AphasiaAphasiaProgressive AphasiaProgressive Aphasia in Alzheimer's Disease
The current study aims to examine the benefits of an education/support group program for individuals with progressive ap…
Austin, United StatesEst. completion May 2030
Primary Progressive AphasiaDementiaDementia, FrontotemporalAlzheimer Disease
Neurodegenerative Diseases
Frontotemporal Lobar Degeneration
Apraxia, Motor
Dysarthria
Communication Disorders
Language Disorders
Speech Disorders
Neurocognitive Disorders
Aphasia
Bilingual Aphasia
Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). Whil…
Austin, United StatesEst. completion Nov 30, 2027